Insider Trading: Celgene Corp (CELG.O)

CELG.O on Nasdaq

93.85USD
19 Sep 2014
Price Change (% chg)

$0.58 (+0.62%)
Prev Close
$93.27
Open
$94.45
Day's High
$94.96
Day's Low
$93.34
Volume
6,051,273
Avg. Vol
4,330,911
52-wk High
$96.44
52-wk Low
$66.85

Search Stocks
All Insider Trades
Trading Date Name Title Type Shares Traded Price
11 Jun 2014

BARKER RICHARD W

Director Buy 1,033 $0.00
11 Jun 2014

CASEY MICHAEL D

Director Buy 1,033 $0.00
11 Jun 2014

BARKER RICHARD W

Director Sell 309 $160.22
11 Jun 2014

DRAKE RODMAN L

Director Buy 1,033 $0.00
11 Jun 2014

KAPLAN GILLA

Director Buy 1,033 $0.00
11 Jun 2014

LOUGHLIN JAMES J

Director Buy 1,033 $0.00
11 Jun 2014

MARIO ERNEST B

Director Buy 1,033 $0.00
8 Jun 2014

CASEY MICHAEL D

Director Buy 15,000 $13.68
8 Jun 2014

KAPLAN GILLA

Director Sell 15,000 $161.62
8 Jun 2014

CASEY MICHAEL D

Director Gift 15,000 $0.00
8 Jun 2014

KAPLAN GILLA

Director Buy 15,000 $13.68
1 May 2014

FOUSE JACQUALYN A

Chief Financial Officer Sell 3,686 $147.40
1 May 2014

HUGIN ROBERT J

Chief Executive Officer Buy 30,000 $0.00
1 May 2014

FOUSE JACQUALYN A

Chief Financial Officer Buy 7,800 $0.00
1 May 2014

HUGIN ROBERT J

Chief Executive Officer Sell 15,555 $147.40
30 Apr 2014

KARSEN PERRY A

Chief Operating Officer Buy 11,667 $59.50
30 Apr 2014

KARSEN PERRY A

Chief Operating Officer Sell 11,922 $146.78
29 Apr 2014

DRAKE RODMAN L

Director Buy 1,000 $38.43
6 Apr 2014

MARIO ERNEST B

Director Buy 6,000 $55.38
24 Mar 2014

MARIO ERNEST B

Director Gift 196 $0.00
24 Mar 2014

MARIO ERNEST B

Director Gift 196 $0.00
12 Mar 2014

HUGIN ROBERT J

Chief Executive Officer Buy 25,168 $42.39
12 Mar 2014

HUGIN ROBERT J

Chief Executive Officer Buy 40,000 $15.49
12 Mar 2014

HUGIN ROBERT J

Chief Executive Officer Sell 58,434 $156.00
12 Mar 2014

HUGIN ROBERT J

Chief Executive Officer Buy 7,897 $59.01

Institutional Holders

% Shares Owned: 83.27%
# of Holders: 1,354
Total Shares Held: 665,785,517
3 Mo. Net Change: 4,708,480
# New Positions: 123
# Closed Positions: 92
# Increased Positions: 546
# Reduced Positions: 636
# Net Buyers: -90

Officers & Directors

Name Age Since Current Position

Robert Hugin

59 2011 Chairman of the Board, President, Chief Executive Officer

Mark Alles

55 2014 President, Chief Operating Officer

Peter Kellogg

58 2014 Chief Financial Officer, Executive Vice President

Jacqualyn Fouse

52 2014 President - Hematology & Oncology

Scott Smith

2014 President - Inflammation & Immunology

Perry Karsen

58 2012 Chief Operations Officer, Executive Vice President

Lawrence Stein

64 2012 Executive Vice President, General Counsel, Corporate Secretary

Thomas Daniel

60 2012 Executive Vice President, President - Research and Early Development

Michael Casey

68 2007 Lead Independent Director

Richard Barker

65 2012 Independent Director

Carrie Cox

56 2009 Independent Director

Michael Friedman

70 2011 Independent Director

Gilla Kaplan

67 1998 Independent Director

James Loughlin

71 2007 Independent Director

Ernest Mario

76 2007 Independent Director
Search Stocks